MYO Stock Analysis: Buy, Sell, or Hold?
MYO - Myomo Inc.
$0.66
0.02 (3.47%)
▲
5d:
-4.98%
30d:
-11.75%
90d:
-28.27%
BUY
MODERATE Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Accumulation
MYO is down 5.4% this week, but smart money is accumulating calls. Top strike: $1 2026-05-15 with 60 OI. Call ratio: 100% View Scanner →
Strength: 7.7/10
Get Alerted When MYO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MYO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: MYO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MYO is currently trading at $0.66, which is considered oversold relative to its 30-day fair value range of $0.68 to $0.77.
Technical Outlook: Technically, MYO is in a strong downtrend. Immediate support is located at $0.63, while resistance sits at $0.74. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: MYO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.32 (+574.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MYO is in a strong downtrend. Immediate support is located at $0.63, while resistance sits at $0.74. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: MYO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.32 (+574.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.68 -
$0.77
Company Quality Score
52/100
(HOLD)
Options IV Signal
60th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
64.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 60th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading 574.9% below Wall St target ($4.32)
Fair Price Analysis
30-Day Fair Range
$0.68 -
$0.77
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.32
(48.4%)
Support & Resistance Levels
Support Level
$0.63
Resistance Level
$0.74
Current Trend
Strong Downtrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.44
Wall Street Target
$4.32
(+574.9%)
Revenue Growth (YoY)
-5.9%
Profit Margin
-38.0%
Share & Embed Analysis
Last updated: March 31, 2026 3:07 PM ET
Data refreshes hourly during market hours. Next update: 4:07 PM
Data refreshes hourly during market hours. Next update: 4:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MYO showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 53 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 52 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 64 BUY |
